Diagnostics Co. Alere To Acquire EScreen For $270M
Health management company Alere Inc. has agreed to purchase toxicology screening company eScreen Inc. for $270 million in a move to strengthen its position in the diagnostics market, Alere announced Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article